Sunlight vs TMates: Cost, meds, and doctor access compared

If you are comparing Sunlight vs TMates, the main trade offs are price and clinical model. Verdict early: Sunlight emphasizes lower starting cost and same-price commitment, while TMates emphasizes a flat $199/month model with 24/7 U.S. doctor access and compounded semaglutide.

Explore Sunlight plans starting at $88/mo

How Sunlight vs TMates differ at a glance

This comparison uses only captured evidence from each provider. It compares five key differences: starting price and pricing model, medication types and formulation, clinician access and oversight, geographic and product availability, and regulatory notes about compounded or branded medications.

1. Price and pricing model

Sunlight: Personalized GLP-1 from $88/mo, promoted as “Same price forever” with no price increases ever and no hidden fees. Evidence includes marketing copy and landing page captures that list plans starting at $88 and a Summer Promo noting “As low as $88.” Sunlight highlights free 1-2 day shipping and statements like “No Monthly Membership” and “Cancel Anytime.”

See Sunlight pricing and terms

TMates: Flat $199/month at every dose, no step-up fees as dosage escalates. TMates materials emphasize a straightforward flat-rate model so cost does not increase as dose increases. Other TMates pricing rows captured show month bundles at varying per month rates for longer commitments, but the core claim is $199/month flat for the program.

2. Medication types and formulation

Sunlight: Offers “injections & oral options” and “Personalized GLP-1” products. The source emphasizes prescription and telehealth included with no insurance required. It does not specify which branded or compounded products are used in the captured evidence. A regulatory note for Sunlight specifies that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.

TMates: Focuses on clinically dosed compounded semaglutide formulated in U.S.-based facilities. TMates notes its semaglutide is compounded and that compounded medications are not FDA approved as finished products. TMates also states it does not offer branded Ozempic, Wegovy, or Zepbound, and highlights the flexibility of compounded dosing.

3. Clinician access and program oversight

Sunlight: Advertises 100% online medical visit with telehealth and clinician involvement captured in landing-page evidence. Claims include clinician reviews and customer reports of clinician dose adjustments, but the source advises users to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment.

TMates: Promotes 24/7 access to U.S.-based doctors and virtual check-in appointments for ongoing medical oversight. The captured FAQ emphasizes actual physician availability not just messaging, and licensed coverage in all 50 states.

View TMates semaglutide program and doctor access

4. Geographic availability and shipping

Sunlight: Landing evidence states free shipping in 1-2 days and free discreet 2-day shipping in promotional copy. Users are still advised to confirm state availability and eligibility prior to enrollment.

TMates: States licensed coverage in all 50 states and that it ships to most states, subject to medical eligibility. TMates emphasizes U.S. formulation of medications and domestic sourcing as part of its quality messaging.

5. Regulatory and product notes

Sunlight: The captured content includes a regulatory note that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.

TMates: Explicitly notes that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. TMates frames compounded semaglutide as giving more dosage flexibility and access at a lower price point versus branded finished products.

Side-by-side comparison table

Criteria	Sunlight	TMates
Starting price	$88/mo starting at, Summer Promo noted	$199/month flat at every dose
Pricing model	Advertises “Same price forever” and no hidden fees	Flat $199/month, no step-up fees
Medication types	Personalized GLP-1 with injections and oral options	Clinically dosed compounded semaglutide formulated in USA
Clinician access	100% online medical visit and telehealth included	24/7 U.S. doctor access and virtual check-ins
States / shipping	Free 1-2 day shipping claimed; state availability should be confirmed	Licensed coverage in all 50 states; ships to most states subject to eligibility
Regulatory note	Medication-specific approval status must be confirmed	Compounded medicines are not FDA approved as finished products

Practical takeaways on Sunlight vs TMates

Sunlight positions itself around lower starting price points from $88/mo, a same-price-forever message, and a mix of injection and oral GLP-1 options with telehealth and prescription included. TMates positions itself around a flat $199/month at every dose, clinically dosed compounded semaglutide formulated in U.S. facilities, and 24/7 U.S. doctor access across all 50 states. Both emphasize shipping and cancel anytime policies but differ on compounded medication disclosure and stated clinician availability.

Check TMates details and availability

Compare Sunlight eligibility and plans

Choose one if…

• Choose Sunlight if you prioritize a lower advertised starting price and a “same price forever” commitment with injections and oral GLP-1 options. Verify eligibility, medication specifics, renewal terms and state availability before enrolling.
• Choose TMates if you prioritize flat-rate pricing at $199/month with consistent physician availability 24/7, clinically dosed compounded semaglutide formulated in U.S. facilities, and licensed coverage in all 50 states. Keep in mind compounded medications are not FDA approved as finished products.

When deciding Sunlight vs TMates, use these captured facts to confirm which model, medication formulation, and clinician access match your priorities.